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Abstract 
A knowledge gradient exists between experts in a given field and consumers of that knowledge. 
When the need arises, not knowing the best path, an average individual typically relies on the ad-
vice of an expert. Given the steep knowledge gradient between patient and provider, clinicians 
play an essential role in the clinical setting, acting as both a health leader and a health facilitator; 
however, this asymmetric information implies that clinical providers face an acute pressure not 
only to advise but to advise correctly. This paper explores the importance of physician advice 
within the context of smoking cessation, addressing two specific research questions: (1) among 
current smokers, do patients have a higher probability of any quit attempts in the last twelve 
months if a physician advised them to quit over the same period? and, (2) among current smokers 
who were advised to quit, do patients have a higher probability of any quit attempts in the past 
twelve months based, at least in part, on the specific quitting strategy suggested by the physician? 
The results suggest that physicians play a crucial role in promoting smoking cessation efforts. The 
findings further highlight a significant association between the advised cessation strategy and any 
quit attempts, although the direction of this relationship varies by the cessation strategy suggest- 
ed. 
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1. Introduction 
Rodney Dangerfield once joked, “I met the surgeon general―he offered me a cigarette.” Like many good jokes, 
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the comedian touches on a fundamental truth: for better or worse, the advice as well as implicit or explicit endor- 
sements by leaders in a field matter. A person cannot be a universal expert. Barring superhuman intellect, most 
individuals will not be well versed in everything from Shakespeare to hadron colliders. Therefore, a knowledge 
gradient exists between experts in a given field and consumers of that knowledge. When the need arises, not 
knowing the best path, an average individual typically relies on the advice of an expert. 
In the context of healthcare, this knowledge gradient is particularly steep. Healthcare is characterized by a 
large degree of asymmetric information. As Phelps (2012) describes, the asymmetry exists since “one party (the 
doctor) generally has considerably, possibly massively, greater level of knowledge than the other (the patient) 
about the issues at hand, namely the diagnosis and treatment of disease,” (pg. 5). Without the clinician’s training 
and experience, patients cannot fully understand diagnostics and treatment strategies or preform essential medi-
cal procedures. As such, clinicians serve as essential and de facto leaders in the healthcare field, serving a con-
stituency of patients who rely on their advice and medical services. 
This asymmetrical information reinforces the clinician’s role as a gatekeeper, shaping a patient’s treatment 
trajectory. For example, despite the large degree of direct-to-consumer advertising, a patient cannot simply pre-
scribe herself medication. Patients legally gain access only when their clinician writes a prescription. Resultantly, 
clinicians not only represent leaders within the health care field but also facilitators of patient health, reinforcing 
the theory that, in field of healthcare, health leadership requires facilitation (Keeler, 2013).  
Given the dramatic knowledge gradient, clinical providers face an acute pressure to not only advise but to ad-
vise correctly. Rathert and colleagues (2011) supports this premise. Drawing on qualitative patient data, the au-
thors explore acute care patients’ perceptions of their role in promoting patient safety. Rathert and colleagues 
(2011) conclude, “[o]verall, most patients appeared to be suggesting that patients should listen, trust, and be co-
operative,” (pg. 139). In fact, one respondent described a patient’s responsibilities as follows, “[t]o listen care-
fully and follow directions of your care givers,” (pg. 138). The work of Rathert and colleagues (2011) indicates 
that many patients take a backseat role in their care, relying on the wisdom of their caregivers. Given that there 
are often multiple solutions to a single problem, providers face the perilous task of advising the most efficacious 
route.  
This paper explores the importance of clinicians’ advice within the context of smoking cessation. Drawing on 
data from the 2010-2011 Tobacco Use Supplement to the Current Population Survey (TUS-CPS), this paper ad-
dresses two specific questions: (1) among current smokers, do patients have a higher probability of any quit at-
tempts in the last twelve months if a physician advised them to quit over the same period? and, (2) among cur-
rent smokers who were advised to quit, do patients have a higher probability of any quit attempts in the past 
twelve months based, at least in part, on the specific quitting strategy suggested by the physician? While mul-
tiple cessation aids exist, this paper focuses on five categories: telephone quit lines, smoking cessation classes, 
programs, or counseling, nicotine products like a patch or gum, prescription products such as Chantix, and set-
ting a quit date.  
This paper is organized as follows: Section two provides a brief background on smoking and smoking cessa-
tion in the United States; section three outlines the methods used, including the data source, sample population, 
key measures, and statistical analysis; section four details the empirical results; and, the fifth and final section 
discusses the implications of these findings in the context of clinical leadership.  
2. Background 
Launched in December of 2010 by the department of Health and Human Services, Healthy People 2020 sets a 
series of health-related objectives to be achieved by 2020, with the vision of creating “a society in which all 
people live long, healthy lives,” (US HHS, 2012). In particular, Healthy People outlines three broad goals sur-
rounding tobacco use; the first of which includes the “[implementation of] policies to reduce tobacco use and in-
itiation among youth and adults,” (CDC, 2013). Thus, the department of Health and Human Services explicitly 
identifies tobacco use as a crucial barrier obstructing the creation of a healthy, long-living society.  
In 1964, the surgeon general released a seminal report, which, for the first time, linked smoking with a num-
ber of adverse outcomes, including all-cause mortality, cancer, and chronic bronchitis (US HHS, 2014). Since 
then, researchers have related smoking with a variety of poor health outcomes, including some unlikely health 
conditions such as diabetes mellitus, rheumatoid arthritis, and colorectal cancer (US HHS, 2014). Facing an ever 
increasing body of evidence demonstrating the perils associated with smoking, local, state, and federal govern-
ments continue to institute policy and regulation aimed at stemming smoking and other tobacco behaviors, in-
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cluding the recent federal Family Smoking Prevention and Tobacco Control Act passed in June 2009 (Pub.L 
111-31, H.R. 1256).  
Aimed at curbing smoking initiation by adolescents and young adults, the Food and Drug Administration 
(FDA, 2013) describes the Tobacco Control Actas “[restricting] tobacco product advertising and marketing to 
youth by directing [the] FDA to issue regulations,” including the prohibition of “reduced harm” claims, further 
restrictions on packaging and advertisements, the elimination of free cigarette samples, and the proscription of 
tobacco sponsorship of sporting and entertainment events (FDA, 2013). As a result of the act, “Cigarette package 
health warnings will be required to cover the top 50 percent of both the front and rear panels of the package, and 
the nine specific warning messages must be equally and randomly displayed and distributed in all areas of the US,” 
(FDA, 2013)1. 
Despite public health awareness campaigns, legislation and regulation, the US currently faces a tobacco use 
epidemic-approximately eighteen percent of US adults age eighteen and over smoke cigarettes (CDC, 2014). 
Indeed, smoking remains the leading preventable cause of premature death in the US (US HHS, 2014).  
Not surprisingly, the economic cost of smoking in terms of health care resources is huge, ranging between 0.6% 
and 0.85% of US gross domestic product (Parrot and Godfrey, 2004). As such, further facilitation of cessation 
efforts present obvious benefits, both in terms of health as well as financial savings.  
In terms of health benefits, at an individual level, cessation is associated with an increase in life expectancy 
and a decrease in the incidence of comorbid disease; self-reported health status also increases, suggesting an 
improvement in an individual’s overall quality of life (Parrot and Godfrey, 2004). Individuals residing with for-
mer smokers share in this improvement, benefiting from reduced exposure to secondhand smoke and the asso-
ciated complications (Parrot and Godfrey, 2004). 
Given the economic and health-related benefits, naturally, an expansive body of research explores the inci-
dence of smoking cessation; nevertheless, experts agree that smoking cessation merits more attention (HHS, 
2014). Most literature defines the incidence of successful cessation as the ratio of newly successful former 
smokers in a given year divided by recent active smokers who are eligible to quit (e.g., Gilpin and Pierce, 2002; 
Chang et al., 2014). “Success” is gauged by having quit for a specific and sufficient period of time, which, in the 
literature, usually ranges from three to six months. For instance, Chang and colleagues (2014) define the annual 
cessation rate as quitting for at least three months among recent active smokers.  
In the United States, the prevalence of cigarette cessation has increased over time. Using National Health In-
terview Survey data, Gilpin and Pierce (2002) find that, among US adults, the “incidence [of quitting] increased 
5 fold” between 1962 and 1992. Exploring smoking behaviors over the subsequent decade (1992 to 2002), 
Pierce and colleagues (2009) observe a continued reduction in the prevalence of cigarette consumption. Drawing 
on the 1992-1993, 1998-1999, and 2006-2007 Tobacco Use Supplement to the Current Population Survey, Jemal 
and colleagues (2011) observe a decrease in the prevalence of smoking between 1992 and 2007.  
Public awareness campaigns, legislation, and regulation shape cessation patterns. For example, Gilpin and 
Pierce (2002) note that following the surgeon general’s report detailing the adverse effects of smoking on health, 
including the health of fetuses, the incidence of cessation increased among young, female smokers in the 1970s. 
The authors also note the positive effect of 1980’s public awareness campaigns aimed at curbing smoking. Jemal 
and colleagues (2011) find a strong, negative correlation between the decreased prevalence of smoking and 
state-level policies regarding cigarette excise taxes and indoor air. 
In some cases, the influence of public awareness campaigns, legislation, and regulation is paralleled in other 
countries. For instance, investigating the impact of the multi-pronged 2009 Taiwanese Tobacco Hazards Preven-
tion Act, which “[extended] smoke-free areas to include almost all enclosed work-places and public places, [ad- 
ded] graphic health warnings to cigarette packages, totally [banned] tobacco advertisements, promotion and spon- 
sorship and [increased] tobacco taxes,” (pg. 140), Chang and colleagues (2014) find that, taken together, the le- 
gislation was associated with a statistically significant increase in quit attempts as well as the annual cessation rate.  
Importantly, demographic and other factors mediate cessation trends. Some dramatic examples surround 
race/ethnicity, socioeconomic indicators, and price. For instance, African Americans consistently exhibit lower 
quit rates relative to Caucasians (e.g., Gilpin and Pierce, 2002), although the impact of education seems to su-
 
 
1While a step in the right direction, the Tobacco Control Act inevitably contains loopholes. For instance, while banning flavoring in ciga-
rettes, menthol flavoring is still permissible. This caveat is of particular importance in the context of smoking cessation since, as Trinida-
dand colleagues (2010) note, “those who used to regularly smoke mentholated cigarettes were less likely to have experienced long-term 
quitting success,” (pg. 84). 
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persede that of race/ethnicity (Gilpin and Pierce, 2002; Keeler et al., 1999). Socioeconomic factors appear to 
further mediate the impact of price. Indeed, some research suggests that individuals of lower socioeconomic 
status are more responsive to price (e.g., Townsend et al., 1994). Investigating the prevalence of smoking in 
Caucasian and African American populations in the southeast and acknowledging the strong correlation between 
socioeconomic indicators and smoking outcomes, Cohen and colleagues (2011) emphasize the importance of 
targeted interventions in high-risk populations. Gender also plays a role; for instance, Townsend and colleagues 
(1994) find that, relative to men, women are less responsive to public health campaigns and more responsive to 
changes in price.  
Building on Cohen and colleagues (2011) argument for targeted interventions, no intervention can be more 
targeted than the cessation strategy devised between a patient and her clinical provider. As such, one of the first 
frontiers of the battle for smoking cessation takes place in the clinical setting. Acting not only as a health leader 
but health facilitator, the clinical provider plays an important role in promoting cessation behaviors. A clinician 
can help initiate cessation efforts by simply broaching the idea of quitting during a patient’s visit; furthermore, 
as suggested by the aforementioned literature, the manner in which a clinician advises cessation and the strate-
gies that he or she recommends likely influences the patient’s probability of success.  
3. Methods 
3.1. Data Source 
The data for this analysis come from the 2010-2011 Tobacco Use Supplement to the Current Population Survey 
(TUS-CPS). Backed by the US Bureau of Labor Statistics and US Bureau of Census, the Current Population 
Survey (CPS) is a nationally representative, primarily cross-sectional survey. The CPS serves as the chief source 
of nationally representative economic and labor market data, administered monthly to approximately 60,000 
households. In addition to these employment data, the CPS also collects essential demographic information.  
The CPS is often accompanied by supplemental surveys. In particular, the National Cancer Institute periodi-
cally sponsors a tobacco use supplement (TUS), which collects data on, among other things, current smoking 
status, tobacco use history, smoking behaviors, tobacco products used, and attitudes towards smoking. Of im-
portance for the present analysis, the 2010-2011 TUS data contain information on cessation recommendations 
by a medical doctor.  
3.2. Sample Population 
The 2010-2011 TUS questionnaire was administered in May 2010, August 2010, and January 2011; observa-
tions across these three waves are consolidated to create a single, pooled cross-section. This study focuses on the 
quit attempts of current, active smokers. Current, active smokers are defined as individuals who identify as eve-
ryday smokers or someday smokers who smoked twelve days or more in the past thirty2. As such, former 
smokers and individuals who have never smoked are excluded from the sample3. The sample population is fur-
ther restricted to individuals age eighteen to sixty-four to enhance the external validity of the results within the 
context of an adult, working-age population. The original pooled cross-section contained 18,345 self-respon- 
dents who identified as current, active smokers age eighteen to sixty-four, who smoke every day or at least 
twelve days in the last thirty. Of this group, 5,139 respondents indicated that they had not visited a doctor in the 
last twelve months and were, therefore, excluded from the sample. Observations with incomplete information 
for the relevant variables were also excluded from the analysis, resulting in a final sample size of 11,726 indi-
viduals.  
3.3. Outcome Measures 
Similar to Chang and colleagues (2014), this paper explores the prevalence of having any quit attempts in the 
last twelve months. The TUS questionnaire asks, “During the past 12 months, have you stopped smoking for one 
day or longer because you were trying to quit?” Therefore, the denominator of this prevalence measure includes 
 
 
2The outcome measure is only asked of someday smokers who smoked twelve or more days in the past thirty, thus limiting the sample pop-
ulation to someday smokers who meet this threshold. 
3Cessation studies often encompass “recent, active smokers,” including former smokers who quit in the last twelve months in the sample 
population; nevertheless, questions relating to physician advice are only asked of someday and everyday smokers, limiting the sample to 
current smokers. 
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all current daily smokers and someday smokers who smoked twelve or more days in the past thirty; the numera-
tor reflects the number within this group who have quit one day or longer with the intention to quit smoking.  
3.4. Physician Measures 
Among those individuals who saw a medical doctor in the past twelve months, the TUS questionnaire asks 
someday and everyday smokers whether any medical doctor advised them to quit smoking. Based on this ques-
tion, a dummy variable was created to reflect whether a medical doctor advised the patient to quit (variable re-
ferred to as ADVISE). 
Among those individuals who were advised to quit smoking by a medical doctor, the TUS questionnaire asks 
whether “In the PAST 12 MONTHS, when a medical doctor advised you to quit smoking, did the doctor also”: 
 “Suggest that you call or use a telephone help line or quit line” 
 “Suggest that you use a smoking cessation class, program, or counseling?” 
 “Recommend or prescribe a nicotine product such as a patch, gum, lozenge, nasal spray or inhaler?” 
 “Prescribe a pill such as Chantix, Varenicline, Zyban, Bupropion, or Wellbutrin? 
 “Suggest that you set a specific date to stop smoking?” 
These five categories are transformed into five separate binary indicators, reflecting whether a physician ad-
vised the use of a help line, class/program/counseling, a nicotine product, other prescription pill, and setting a 
quit date (variables referred to as HELP, CLASS, NICOTINE, PILL, and DATE, respectively).  
3.5. Demographic Measures 
In addition to the physician indictors, demographic and socioeconomic variables are incorporated into the analy-
sis. These variables include indicators relating to gender, race/ethnicity, family income, education, marital status, 
employment status, and geographic region (Northeast, West, South, and Midwest). These demographic variables 
capture the key mediating factors discussed in the previous background section.  
3.6. Statistical Analysis 
The data are analyzed using Stata 13, a statistical software package. All estimates are weighted. Mirroring 
Chang and colleagues’ (2014) statistical analysis, the paper first presents the results from a bivariate chi-squared 
test, which assesses differences in quit attempts across physician indicators and other demographic categories.  
Next, the paper uses logistic regression techniques to investigate whether physician cessation advice over a 
twelve-month period is positively associated with quitting for at least one day over the same period. Specifically, 
the paper presents the results from two multivariate logistic regressions. The first analysis regresses any quit at-
tempts on the physician advice variable (ADVISE) and the remaining covariates. Among those individuals 
whose physicians advised them to quit, the second analysis regresses any quit attempts on the five cessation- 
strategy indicators (HELP, CLASS, NICOTINE, PILL, and DATE) and the remaining covariates. 
4. Results 
4.1. Demographic Characteristics 
Table 1 presents basic summary statistics. The sample population consists of current, active smokers age eigh-
teen to sixty-four, who smoke every day or at least twelve days in the last thirty. The sample population is ap-
proximately equally divided between men and women. The population is also equally distributed between the 
three narrow age categories (eighteen to twenty-four; twenty-five to forty-nine; and, fifty to sixty-four). The ty- 
pical or average person in the sample identifies as Caucasian, has a family income between $50,000 and $74,999 
per year, has a high school education, is married, and employed. Sixty-six percent of the population has been 
advised by a medical doctor to quit smoking.  
4.2. Prevalence of Any Quit Attempts in the Past Twelve Months among Current Smokers 
by Demographic Characteristics 
Table 2 presents prevalence of any quit attempts in the past twelve months (i.e., quit for at least one day with 
the intention of quitting). A bivariate chi-squared test assesses differences in quit attempts across physician in 
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Table 1. Descriptive statistics.                                                                              
 N Mean SE 
Advise on smoking cessation in last 12 months 11,726 1.00  
Doctor did not advise to quit  0.339 (0.00495) 
Doctor advised to quit  0.661 (0.00495) 
Cessation strategy advised by doctor in last 12 months    
Quit line 8222 1.000  
Quit line not suggested  0.801 (0.00495) 
Quit line suggested  0.199 (0.00495) 
Class/program/counseling 8222 1.000  
Class/program/counseling not suggested  0.827 (0.00468) 
Class/program/counseling suggested  0.173 (0.00468) 
Nicotine product 8222 1.000  
Nicotine product not suggested  0.730 (0.00549) 
Nicotine product suggested  0.270 (0.00549) 
Prescription product 8222 1.000  
Prescription product not suggested  0.756 (0.00529) 
Prescription product suggested  0.244 (0.00529) 
Setting a quit date 8222 1.000  
Quit date not suggested  0.807 (0.00491) 
Quit date suggested  0.193 (0.00491) 
Gender 11,726 1.000  
Female  0.512 (0.00878) 
Male  0.488 (0.00878) 
Age 11,726 1.000  
18 to 24 (Omitted)  0.334 (0.00531) 
25 to 49  0.324 (0.00477) 
50 to 64  0.342 (0.00482) 
Race/ethnicity 11,726 1.000  
White (Omitted)  0.776 (0.00472) 
African American  0.109 (0.00355) 
Native American  0.00972 (0.000906) 
Asian  0.0174 (0.00147) 
Pacific islander  0.00165 (0.000396) 
Hispanic  0.0694 (0.00292) 
Other  0.0178 (0.00141) 
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Continued  
Family income 11,726 1.000  
$0 to $24,999  0.228 (0.00466) 
$25,000 to $49,999  0.206 (0.00455) 
$50,000 to $74,999  0.115 (0.00349) 
$75,000 to $99,999  0.0638 (0.00279) 
$100,000+ (Omitted)  0.388 (0.00511) 
Highest level of educational attainment 11,726 1.000  
>12th  0.145 (0.00370) 
12th or equivalent  0.631 (0.00493) 
Associate degree  0.0999 (0.00296) 
Bachelor's degree  0.0978 (0.00307) 
At least some graduate school (Omitted)  0.0270 (0.00157) 
Marital status 11,726 1.000  
Never married (Omitted)  0.295 (0.00507) 
Married  0.430 (0.00532) 
Widowed  0.0314 (0.00167) 
Divorced  0.196 (0.00397) 
Separated  0.0468 (0.00213) 
Employment status 11,726 1.000  
Unemployed (Omitted)  0.108 (0.00335) 
Employed  0.605 (0.00514) 
Not in labor force  0.287 (0.00469) 
Geographic region 11,726 1.000  
West (Omitted)  0.165 (0.00418) 
Northeast  0.174 (0.00452) 
Midwest  0.275 (0.00516) 
South  0.385 (0.00572) 
Notes: (a) All estimates weighted. (b) Sample population consists of all current everyday and some day smokers who smoked on at least 12 days in 
the last 30. (c) Cessation strategies (i.e., quit line, class/program/counseling, nicotine product, prescription product, and setting a quit date) only ana-
lyzed among those individuals who were advised to quit smoking by a medical doctor, resulting in a smaller sample size. 
 
dicators and other demographic categories (as seen by the p-values in the table). The test indicates several key 
differences, including difference between those who were advised to quit by a medical doctor and those who 
were not. Among those individuals advised to quit by a medical doctor, the bivariate chi-squared test signals es-
sential differences between those who were advised to use a class, program, or counseling compared to those 
who were not, those who were advised to use a prescription product compared to those who were not, and those 
who were advised to set a quit date compared to those who were not.  
4.3. Multiple Logistic Regression Analysis: The Relationship between Physician Advice 
and Any Quit Attempts 
Regression (1) in Table 3 details the results. As expected, the coefficient on physician advice is statistically sig- 
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Table 2. Prevalence of any quit attempts in the past twelve months among current smokers by demographic characteristics.   
 % 95% CI (95 min, 95 max) p-Value 
Advise on smoking cessation in last 12 months    0.0000 
Doctor did not advise to quit (Omitted) 37.53% 35.82% 39.25%  
Doctor advised to quit 42.79% 41.57% 44.01%  
Cessation strategy advised by doctor in last 12 months     
Quit line    0.5531 
Quit line not suggested (Omitted) 42.97% 41.60% 44.34%  
Quit line suggested 42.07% 39.43% 44.71%  
Class/program/counseling    0.0702 
Class/program/counseling not suggested (Omitted) 43.29% 41.94% 44.64%  
Class/program/counseling suggested 40.40% 37.59% 43.21%  
Nicotine product    0.2494 
Nicotine product not suggested (Omitted) 43.21% 41.78% 44.65%  
Nicotine product suggested 41.65% 39.38% 43.92%  
Prescription product    0.0000 
Prescription product not suggested (Omitted) 40.07% 38.67% 41.46%  
Prescription product suggested 51.24% 48.86% 53.62%  
Setting a quit date    0.0000 
Quit date not suggested (Omitted) 40.42% 39.06% 41.77%  
Quit date suggested 52.74% 50.03% 55.45%  
Gender    0.6483 
Female (Omitted) 41.23% 39.93% 42.52%  
Male 40.77% 39.27% 42.27%  
Age    0.0000 
18 to 24 (Omitted) 46.08% 44.16% 48.01%  
25 to 49 39.77% 38.12% 41.42%  
50 to 64 37.23% 35.68% 38.78%  
Race/ethnicity    0.0007 
White (Omitted) 40.20% 39.09% 41.31%  
African American 46.24% 42.99% 49.48%  
Native American 42.45% 33.33% 51.56%  
Asian 34.60% 26.69% 42.51%  
Pacific islander 70.58% 49.33% 91.84%  
Hispanic 41.45% 37.41% 45.50%  
Other 45.45% 37.83% 53.07%  
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Continued  
Family income    0.0824 
$0 to $24,999 40.70% 38.57% 42.83%  
$25,000 to $49,999 40.13% 37.91% 42.35%  
$50,000 to $74,999 38.78% 35.87% 41.69%  
$75,000 to $99,999 38.73% 34.66% 42.80%  
$100,000+ (Omitted) 42.69% 41.13% 44.26%  
Highest level of educational attainment    0.0813 
>12th 38.32% 35.68% 40.96%  
12th or equivalent 41.00% 39.74% 42.27%  
Associate degree 44.01% 40.99% 47.04%  
Bachelor’s degree 41.55% 38.40% 44.70%  
At least some graduate school (Omitted) 42.49% 36.79% 48.19%  
Marital status    0.0013 
Never married (Omitted) 44.01% 41.99% 46.03%  
Married 40.31% 38.85% 41.78%  
Widowed 36.23% 31.15% 41.32%  
Divorced 39.07% 37.01% 41.13%  
Separated 39.88% 35.42% 44.34%  
Employment status    0.0009 
Unemployed (Omitted) 46.07% 42.87% 49.28%  
Employed 40.96% 39.68% 42.24%  
Not in labor force 39.23% 37.43% 41.03%  
Geographic region    0.0407 
West (Omitted) 42.21% 39.78% 44.64%  
Northeast 41.69% 39.23% 44.14%  
Midwest 42.42% 40.56% 44.28%  
South 39.19% 37.56% 40.81%  
Notes: (a) All estimates weighted. (b) Sample population consists of all current everyday and some day smokers who smoked on at least 12 days in 
the last 30. (c) The denominator of this prevalence measure includes all current daily smokers and someday smokers who smoked twelve or more 
days in the past thirty; the numerator reflects the number within this group who have quit one day or longer. (d) Sample sizes correspond to values 
detailed in Table 1. (e) P-values from chi-squared test. 
 
nificant and positively associated with the probability of having quit at least for one day in the last twelve 
months. Among current smokers who had a medical doctor advise them to quit, the odds of quitting for at least 
one day with the intention to quit (versus not quitting for at least one day) increase by a factor of 1.315 relative 
to those smokers who did not receive such advice, adjusting for the additional covariates.  
Additionally, younger smokers appear more likely to quit relative to older smokers. While the majority of 
race/ethnicity variables are insignificant, African Americans and Pacific Islanders appear more likely to quit 
smoking for one day or longer relative to Caucasian smokers (p < 0.001 and p < 0.05, respectively). This result 
has some support in the literature. For instance, Keeler and colleagues (1999) find that African Americans have 
fewer failed quit attempts but also fewer successful occurrences of cessation. The odds of any quit attempts in-
crease with education, supporting the existing literature (e.g., Gilpin and Pierce, 2002; Keeler et al., 1999). 
Compared to the unemployed, employed individuals and those individuals not part of the labor force have lower 
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odd of quitting. This result may reflect one’s finances-if cigarettes are a normal good (meaning, demand in-
creases as income increases), those without income may quit simply because they cannot afford the expense. 
Finally, southerners have lower odds of quitting for at least one day with the intention quit relative to those liv-
ing in the west (p < 0.05). 
4.4. Multiple Logistic Regression Analysis: The Relationship between Cessation Strategy 
Advice and Any Quit Attempts among Those Individuals Advised to Quit Smoking by a 
Medical Doctor 
Regression (2) in Table 3 details the results. The relationship between cessation strategy and the likelihood of 
quitting varies by the cessation strategy advised. With the exception of help/quit lines, all cessation strategies are sta- 
tistically significant. The Wald test indicates that the cessation variables (HELP, CLASS, NICOTINE, PILL, and 
DATE) are jointly significant (p < 0.000). Nevertheless, the direction of these effects is not consistently positive.  
Among those whose medical doctor suggested using or prescribed a product such as Chantix, the odds of 
quitting for at least one day with the intention to quit (versus not quitting for at least one day) increase by a fac-
tor of 1.564 relative to those smokers who did not receive such advice, adjusting for the additional covariates. Si-
milarly, among current smokers whose doctor medical doctor suggested setting a quit date, the odds of quitting for 
at least one day with the intention to quit increase by a factor of 1.626 relative to those smokers who did not re-
ceive such advice, adjusting for the additional covariates. Interestingly, while both positive, the impact of setting 
a quit date seems to slightly supersede that of prescription drugs, at least in terms of the magnitude of the effect. 
While having a medical doctor suggest prescription medications or setting a quit date in the last twelve 
months are positively associated with the odds of having quit for at least one day over the same period (versus 
those who did not receive this advice), other cessation recommendations relating to nicotine products and 
classes/counseling run in the opposite direction. Smokers advised to use a nicotine product had lower odds of 
any quit attempts in the last year relative to smokers who did not have a physician make such a recommendation. 
Similarly, smokers who were advised to attend a class, program, or counseling also had lower odds of quitting 
for at least one day compared to smokers who did not receive this advice.  
Once again, several of the remaining covariates are significant, and run in the same direction as observed in 
regression (1). 
5. Discussion 
The results suggest that physicians play a crucial role in promoting smoking cessation efforts. The empirical 
analysis reveals that current smokers who were advised to quit by a medical doctor in the past twelve months 
had higher odds of quitting at least one day with the intention to quit over the same period compared to smokers 
who did not receive such advice.  
Among those advised to quit by a medical doctor, the findings further highlight a significant association be-
tween suggested cessation strategies and any quit attempts in the last year, although the direction of this rela-
tionship varies by the cessation strategy recommended. Smokers advised to use a nicotine product or attend a 
class, program, or counseling had lower odds of quitting for at least one day relative to patients not recom-
mended these strategies. Comparatively, smokers advised to use a prescription product like Chantix or set a quit 
date experienced a higher odds of any quit attempts relative to those who did not receive this advice. 
These results complement the existing literature. For instance, summarizing their results, Fiore and colleagues 
(1990) write, “The cessation method used was the strongest predictor of success. Among smokers who had at-
tempted cessation within the previous 10 years, 47.5% of persons who tried to quit on their own were successful 
whereas only 23.6% of persons who used cessation programs succeeded,” (pg. 2760). These results parallel the 
findings of the current work, which indicate that autonomously driven endeavors, like setting a quit date, are 
more strongly and positively associated with any quit attempts compared to classes, programs, or counseling.  
Selection effects may partially explain the observed variation in the odds of any quit attempts across the varying 
cessation strategies. Cessation strategies may be associated with differing financial and time costs, drawing sys-
tematically different types of smokers. Indeed, we have already seen that income and smoking are related. Addi-
tionally, cessation strategies may also vary with smoking intensity. Perhaps a physician may be more likely to 
advise a nicotine product or class for heavy smokers; this may explain why smokers advised with these strategies 
are less likely to have any quit attempts. Finally, some cessation strategies may be gradual in nature, resulting in 
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Table 3. Multiple logistic regressions assessing the association between physician advice and any quit attempts in the later 
twelve months.                                                                                          
 
(1) 
Any quit attempts, past 12 months 
(2) 
Any quit attempts, past 12 months  
(Conditional on a medical doctor 
advising individual to quit) 
 Adj. OR CI Adj. OR CI 
Advise on smoking cessation in last 12 months     
Doctor did not advise to quit 1 Reference --  
Doctor advised to quit 1.315*** [1.203, 1.438] --  
Cessation strategy advised by doctor in last 12 months     
Quit line not suggested --  1 Reference 
Quit line suggested --  0.933 [0.805, 1.082] 
Class/program/counseling not suggested --  1 Reference 
Class/program/counseling suggested --  0.815* [0.697, 0.954] 
Nicotine product not suggested --  1 Reference 
Nicotine product suggested --  0.840** [0.744, 0.950] 
Prescription product not suggested --  1 Reference 
Prescription product suggested --  1.564*** [1.387, 1.764] 
Quit date not suggested --  1 Reference 
Quit date --  1.626*** [1.418, 1.864] 
Gender     
Female 1 Reference 1 Reference 
Male 0.996 [0.917, 1.082] 0.964 [0.870, 1.067] 
Age     
18 to 24 1 Reference 1 Reference 
25 to 49 0.748*** [0.670, 0.836] 0.771*** [0.670, 0.889] 
50 to 64 0.670*** [0.597, 0.753] 0.678*** [0.587, 0.783] 
Race/ethnicity     
White 1 Reference 1 Reference 
African American 1.360*** [1.178, 1.570] 1.655*** [1.388, 1.974] 
Native American 1.098 [0.757, 1.594] 1.110 [0.717, 1.719] 
Asian 0.726 [0.512, 1.030] 0.784 [0.504, 1.218] 
Pacific islander 3.253* [1.197, 8.841] 3.615 [0.902, 14.49] 
Hispanic 1.062 [0.889, 1.269] 1.193 [0.953, 1.493] 
Other 1.184 [0.866, 1.618] 1.213 [0.831, 1.772] 
Family income     
$0 to $24,999 0.906 [0.808, 1.016] 1.008 [0.878, 1.157] 
$25,000 to $49,999 0.894 [0.798, 1.002] 0.916 [0.793, 1.058] 
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Continued  
$50,000 to $74,999 0.853* [0.741, 0.983] 0.857 [0.724, 1.014] 
$75,000 to $99,999 0.841 [0.700, 1.011] 0.879 [0.705, 1.097] 
$100,000+ 1 Reference 1 Reference 
Highest level of educational attainment     
>12th 1 Reference 1 Reference 
12th or equivalent 1.133 [0.998, 1.286] 1.162 [0.999, 1.353] 
Associate degree 1.335*** [1.124, 1.585] 1.305* [1.061, 1.606] 
Bachelor's degree 1.202* [1.007, 1.436] 1.345** [1.086, 1.665] 
At least some graduate school 1.310* [1.006, 1.705] 1.578** [1.146, 2.172] 
Marital status     
Never married 1 Reference 1 Reference 
Married 1.026 [0.916, 1.148] 1.042 [0.905, 1.201] 
Widowed 0.938 [0.734, 1.198] 1.020 [0.764, 1.360] 
Divorced 0.992 [0.871, 1.130] 1.019 [0.869, 1.196] 
Separated 0.973 [0.791, 1.197] 1.071 [0.831, 1.381] 
Employment status     
Unemployed 1 Reference 1 Reference 
Employed 0.831* [0.720, 0.958] 0.839 [0.702, 1.003] 
Not in labor force 0.818* [0.701, 0.954] 0.831 [0.688, 1.004] 
Geographic region     
West 1 Reference 1 Reference 
Northeast 0.972 [0.841, 1.122] 0.927 [0.777, 1.105] 
Midwest 1.000 [0.880, 1.138] 0.954 [0.815, 1.117] 
South 0.879* [0.777, 0.995] 0.857* [0.735, 1.000] 
Notes: (a) Adj. OR = adjusted odds ratio; CI = 95% confidence interval. (b) *p < 0.05, **p < 0.01, ***p < 0.001. (c) All estimates weighted. (d) n = 
11,726 and n = 8222 for regressions (1) and (2), respectively. 
 
long-term cessation trajectories. Under this assumption, an individual may be less likely to quit for a single day; 
nonetheless, she may be slowly reducing her tobacco consumption over the long run.  
While ‘any quit attempts’ is a crucial indicator, other, equally important cessation measures must be explored 
within this paradigm. Future research might also investigate the prevalence of three and six-month cessation 
measures as well as the intention to quit among current smokers. The impact of physician advice may be distinct 
across cessation outcomes, influencing single day attempts but not having a durational effect on long-term ces-
sation or shaping an individual’s intention to quit.  
In addition to alternative cessation measures, one might also explore the influence of varying clinical providers. 
An individual encounters several clinical providers, not just medical doctors-nurses, nurse practitioners, physician 
assistants, dentists, dental hygienists, etc. While advice from a medical doctor appears to significantly and posi-
tively impact the probability of any quit attempts, advice from other clinical providers potentially plays an im-
portant role as well. For instance, the literature suggests that nurse practitioners provide comparable primary care 
services (e.g., Mundinger et al., 2000); moreover, a growing number of patients see a nurse practitioner as their 
primary care provider. As such, nurse practitioners likely impact cessation efforts. Along these lines, the influence 
of clinician advice on cessation must be explored through the lens of non-physician providers if we are to capture 
a fuller picture. The 2010-2011 TUS-CPS contains data on cessation advice from a dentist, asking “During the 
PAST 12 MONTHS, did any dentist ADVISE you to stop smoking?” The TUS-CPS also includes the associated 
data relating to cessation strategies, offering a logical next step in this research.  
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Machiavelli famously advised, “The end justifies the means.” Based on the current paper, one might instead 
argue that the “the means impacts the end.” Given the steep knowledge gradient between patient and provider, 
physicians play an essential role in the clinical setting, acting as both a health leader and a health facilitator; 
however, this asymmetric information implies that clinical providers face an acute pressure not only to advise 
but to advise correctly. The findings emphasize that a physician can help initiate smoking cessation by simply 
broaching the topic of quitting with a patient; nevertheless, “the means impacts the end,” i.e., the cessation 
strategy advised may further mediate the probability of successfully quitting or at least attempting to quit.  
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